Ireland has been chosen by biomanufacturing company WuXi Biologics as it seeks to establish a foothold in Europe for its first manufacturing site outside of China. At a 26-hectare campus adjacent to the M1 motorway, it will employ 400 people in what is currently an IDA greenfield site at Mullagharlin, Dundalk.
The company will establish a 325m biologics drug substance manufacturing facility and chief executive officer Dr Chris Chen said: “We want to build a global manufacturing network and this is the start.” Wuxi Biologics’ decision that it was planning to develop a manufacturing facility at Mullagharlin near Dundalk was hailed as a victory for the border county yesterday.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
